• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sanjivani Paranteral Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 6710.0
  • ISIN : INE860D01013
239.70 -11 (-4.56%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    238.60

  • Today’s High

    263.00

  • Open

    263.00

  • Perv Close

    251.15

  • 52W Low

    138.00

  • 52W High

    396.95

Key Indicators

  • P/E(TTM)

    39.75

  • Mar.Cap (₹Cr.)

    284.80

  • Div & Yield %

    0.00

  • Book Value(₹)

    29.10

  • Debt-Equity Ratio

    -4.56

  • AGM Date

    28-Mar-2025

  • EPS

    6.03

  • P/E Ratio

    39.75

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    284.80

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    11.88

  • BV (₹)

    29.10

  • Sales( ₹ in Cr.)

    58.95

  • NP (in Cr.)

    6.17

  • NP Var(%)

    36.0

  • Div%

    0.0

  • CPS (₹)

    6.00

  • EPS (₹)

    5.20

  • Traded Value (₹ in Lakhs)

    284.80

  • 52 Week High

    396.95

  • 52 Week Low

    138.00

  • Price BSE

    240.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    284.80

  • P/C Ratio

    40.20

  • P/E Ratio

    46.30

  • Price Vs.BV

    5.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 54.41 35.49 30.61 25.10 16.36 25.09
Excise Duty 52.29 39.51 27.70 23.08 15.45 23.00
Net Sales 54.41 35.49 30.61 25.10 16.36 25.09
Other Income 0.52 0.55 0.24 0.26 0.25 0.96
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 54.93 36.05 30.86 25.36 16.61 26.05
EXPENDITURE :
Raw Materials 52.29 39.51 27.70 23.08 15.45 23.00
Power & Fuel Cost 52.29 39.51 27.70 23.08 15.45 23.00
Employee Cost 4.10 3.27 3.09 2.49 2.61 2.73
Other Manufacturing Expenses 0.12 -0.23 -0.33 1.25 1.48 5.20
Selling & Administrative Expenses 9.15 5.00 6.89 2.58 2.37 2.54
Miscellaneous Expenses 0.12 -0.23 -0.33 1.25 1.48 5.20
Less : Pre-operative Expenses Capitalised :
Total Expenditure 47.36 31.10 25.98 23.95 18.42 28.35
Operating Profit 4.32 3.25 2.94 1.83 1.15 1.31
Interest 0.25 0.36 0.21 0.13 0.66 0.33
Gross Profit 7.57 4.94 4.88 1.41 -1.81 -2.30
Depreciation 0.93 0.89 0.88 0.86 1.07 1.17
Profit Before Tax 7.57 4.94 4.88 1.41 -1.81 -2.30
Tax 1.35 0.81 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 -0.61 0.03 -0.01 0.00 -0.23
Reported Net Profit 6.17 4.51 4.85 1.42 -1.71 -2.07
Extraordinary Items 7.57 4.94 4.88 1.41 -1.81 -2.30
Adjusted Net Profit 6.17 4.51 4.85 1.42 -1.71 -2.07
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 6.17 4.51 4.85 1.42 -1.71 -2.07
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.28 4.51 4.85 1.67 -2.90 -3.50
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    27.67%

  • Public Share Holding

    72.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,233,061 27.67 3,233,061 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,233,061 27.67 3,233,061 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 600,000 5.14 600,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 130,802 1.12 130,802 1
Sub total 730,802 6.25 730,802 2
2] Non Institution
Bodies Corporate 992,244 8.49 992,244 55
Clearing Members 165 0.00 165 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 70,719 0.61 70,219 97
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 337,910 2.89 337,910 155
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,471,156 29.71 3,471,156 31
Individuals holding nominal share capital up to Rs. 1 lakh 2,848,143 24.38 2,789,853 6,272
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 100 1
Others 0 0.00 0 0
Sub Total 7,720,437 66.08 7,661,647 6,614
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,684,300 100.00 11,625,510 6,618

Company Background

Sanjivani Paranteral LtdPharmaceuticals - Indian - Formulations

  • Sanjivani Paranteral Ltd
  • BSE Code : 6710.0
  • ISIN : INE860D01013

  • Incorporation Year

    1994

  • Registered Office

    205 P N Khotari Indl Estate
    LBS Marg Bhandup (West), Mumbai,
    Maharashtra-400078

  • Telephone

    91-22-67290900

  • FAX

    91-22-67290930

  • Chairman

    Ashwin Khemka

  • Managing Director

    Ashwin Khemka

  • Company Secretary

  • Auditor

    R B Gohil & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sanjivani Paranteral Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sanjiv.Parant. 239.70 54.93 54.41 39.75 11.43
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92